Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles

Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2004-10, Vol.284 (1), p.13-21
Hauptverfasser: Raula, Janne, Eerikäinen, Hannele, Kauppinen, Esko I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21
container_issue 1
container_start_page 13
container_title International journal of pharmaceutics
container_volume 284
creator Raula, Janne
Eerikäinen, Hannele
Kauppinen, Esko I.
description Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5 g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130 nm and from 65 to 100 nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10 wt.% of ketoprofen was added to the precursor solution.
doi_str_mv 10.1016/j.ijpharm.2004.07.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66925609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517304004417</els_id><sourcerecordid>66925609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</originalsourceid><addsrcrecordid>eNqFkU1r3DAQQEVpaDZpf0KDL-3NzujT9qmU0CYLgVzas9DKY6LFlhzJDuy_j9w15FgkENK8GY2eCPlKoaJA1e2xcsfp2cSxYgCigroC4B_IjjY1L7mo1UeyA143paQ1vyRXKR0BQDHKP5FLKoUUrGU7gnvfDwt6i0Xoi_kZixSGV_RzYcM4heRmF3yR5xoyGEMOF-nk8za5tOb8a8JYXGZnzVBMYTiNGAtvfJhMzIcDps_kojdDwi_bek3-_v715-6hfHy639_9fCytkPVc0pYyZZEyCcYqgSDrTvKD4sYKrgR0EtoOW2tl14hGoDqAlXlQicAapvg1-X6uO8XwsmCa9eiSxWEwHsOStFItkwraDMozaPOLUsReT9GNJp40Bb361Ue9-dWrXw21zn5z3s12wXIYsXvP2oRm4NsGmJR19NF469I7p2hDOYPM_ThzmHW8Oow6Wbd-Q-ci2ll3wf2nlTcIqp03</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66925609</pqid></control><display><type>article</type><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</creator><creatorcontrib>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</creatorcontrib><description>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5 g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130 nm and from 65 to 100 nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10 wt.% of ketoprofen was added to the precursor solution.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2004.07.003</identifier><identifier>PMID: 15454292</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aerosol ; Aerosols - chemical synthesis ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Drug ; Eudragit ; General pharmacology ; Medical sciences ; Nanoparticles ; Nanostructures - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymer ; Polymers - chemical synthesis ; Solvents - chemistry</subject><ispartof>International journal of pharmaceutics, 2004-10, Vol.284 (1), p.13-21</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2004.07.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16181320$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15454292$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raula, Janne</creatorcontrib><creatorcontrib>Eerikäinen, Hannele</creatorcontrib><creatorcontrib>Kauppinen, Esko I.</creatorcontrib><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5 g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130 nm and from 65 to 100 nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10 wt.% of ketoprofen was added to the precursor solution.</description><subject>Aerosol</subject><subject>Aerosols - chemical synthesis</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug</subject><subject>Eudragit</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Nanoparticles</subject><subject>Nanostructures - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymer</subject><subject>Polymers - chemical synthesis</subject><subject>Solvents - chemistry</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3DAQQEVpaDZpf0KDL-3NzujT9qmU0CYLgVzas9DKY6LFlhzJDuy_j9w15FgkENK8GY2eCPlKoaJA1e2xcsfp2cSxYgCigroC4B_IjjY1L7mo1UeyA143paQ1vyRXKR0BQDHKP5FLKoUUrGU7gnvfDwt6i0Xoi_kZixSGV_RzYcM4heRmF3yR5xoyGEMOF-nk8za5tOb8a8JYXGZnzVBMYTiNGAtvfJhMzIcDps_kojdDwi_bek3-_v715-6hfHy639_9fCytkPVc0pYyZZEyCcYqgSDrTvKD4sYKrgR0EtoOW2tl14hGoDqAlXlQicAapvg1-X6uO8XwsmCa9eiSxWEwHsOStFItkwraDMozaPOLUsReT9GNJp40Bb361Ue9-dWrXw21zn5z3s12wXIYsXvP2oRm4NsGmJR19NF469I7p2hDOYPM_ThzmHW8Oow6Wbd-Q-ci2ll3wf2nlTcIqp03</recordid><startdate>20041013</startdate><enddate>20041013</enddate><creator>Raula, Janne</creator><creator>Eerikäinen, Hannele</creator><creator>Kauppinen, Esko I.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041013</creationdate><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><author>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aerosol</topic><topic>Aerosols - chemical synthesis</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug</topic><topic>Eudragit</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Nanoparticles</topic><topic>Nanostructures - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymer</topic><topic>Polymers - chemical synthesis</topic><topic>Solvents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raula, Janne</creatorcontrib><creatorcontrib>Eerikäinen, Hannele</creatorcontrib><creatorcontrib>Kauppinen, Esko I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raula, Janne</au><au>Eerikäinen, Hannele</au><au>Kauppinen, Esko I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2004-10-13</date><risdate>2004</risdate><volume>284</volume><issue>1</issue><spage>13</spage><epage>21</epage><pages>13-21</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5 g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130 nm and from 65 to 100 nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10 wt.% of ketoprofen was added to the precursor solution.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15454292</pmid><doi>10.1016/j.ijpharm.2004.07.003</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2004-10, Vol.284 (1), p.13-21
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_66925609
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Aerosol
Aerosols - chemical synthesis
Biological and medical sciences
Chemistry, Pharmaceutical
Drug
Eudragit
General pharmacology
Medical sciences
Nanoparticles
Nanostructures - chemistry
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polymer
Polymers - chemical synthesis
Solvents - chemistry
title Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A22%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20the%20solvent%20composition%20on%20the%20aerosol%20synthesis%20of%20pharmaceutical%20polymer%20nanoparticles&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Raula,%20Janne&rft.date=2004-10-13&rft.volume=284&rft.issue=1&rft.spage=13&rft.epage=21&rft.pages=13-21&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2004.07.003&rft_dat=%3Cproquest_cross%3E66925609%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66925609&rft_id=info:pmid/15454292&rft_els_id=S0378517304004417&rfr_iscdi=true